DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly-owned subsidiary, IMS Health Incorporated, intends to raise €275 million in gross proceeds through an offering of senior notes due 2023. The net proceeds from the notes offering will be used to fund a portion of the purchase price for IMS Health’s previously announced proposed acquisition of certain customer relationship management and strategic data businesses of Cegedim, SA and for related fe